<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">AMPRENAVIR</span><br/>(am-pre'na-vir)<br/><span class="topboxtradename">Agenerase<br/></span><b>Classifications:</b> <span class="classification">antiinfective</span>; <span class="classification">antiretroviral agent</span>; <span class="classification">protease inhibitor</span><br/><b>Prototype: </b>Saquinavir<br/><b>Pregnancy Category: </b>C<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>50 mg capsules; 15 mg/mL oral solution</p>
<h1><a name="action">Actions</a></h1>
<p>Amprenavir inhibits the activity of HIV-1 protease enzyme and thus prevents the cleavage of viral polyproteins essential for
         the maturation and proliferation of the HIV-1 virus.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>The protease inhibitor activity results in the formation of immature, noninfectious viral particles. Amprenavir results in
         reduction of the viral load (HIV-RNA) in the plasma and an increase in the CD<sub>4</sub> lymphocyte cell count.
      </p>
<h1><a name="uses">Uses</a></h1>
<p>Treatment of HIV infection in combination with other antiretroviral agents.</p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Prior sensitivity to amprenavir; pregnancy (category C); lactation, oral solution in children 
      </p><h1><a name="precaution">Cautious Use</a></h1>
<p>History of hypersensitivity to other protease inhibitors (e.g., indinavir, ritonavir, saquinavir); hypersensitivity to sulfonamides;
         hepatic dysfunction; diabetes mellitus; diabetic ketoacidosis, hemophilia A and B; vitamin K deficiencies; anticoagulant therapy,
         oral contraceptives; coadministration with rifampin or sildenafil; antimicrobial resistance, hypercholesterolemia, hypertriglycerides,
         hyperglycemia, females, children, hepatic or renal impairment.
      </p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">HIV Infection</span><br/><span class="rdage">Adult/</span><span class="rdage">Adolescent:</span> <span class="rdroute">PO</span> 1200 mg capsules b.i.d.<br/><span class="rdage">Child:</span> <span class="rdroute">PO</span>
<i>412 y or  20 mg/kg b.i.d. capsules or 15 mg/kg t.i.d. capsules (max: 2400 mg/d); 22.5 mg/kg b.i.d. oral solution or 17 mg/kg t.i.d.
               oral solution<br/><br/><span class="impairmenttitle">Hepatic Impairment</span><br/>Child-Pugh score of 58 give 450 mg b.i.d., Child-Pugh score 912 give 300 mg b.i.d.<br/><br/></i></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Oral</span><br/><ul>
<li>Give without regard to food, BUT not with high fat meal.</li>
<li>Capsules &amp; oral solution are not interchangeable on mg-for-mg basis.</li>
<li>Give 1 h before/after antacid.</li>
<li>Store tablets at 20°25° C (68°77° F). Do not refrigerate.</li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">CNS:</span>
<span class="speceff-common">Oral/perioral paresthesia,</span> peripheral paresthesia, depression, mood disorders. <span class="typehead">GI:</span>
<span class="speceff-common">Nausea, vomiting, diarrhea,</span> taste disorders, increased triglycerides, hyperglycemia. <span class="typehead">Skin:</span>
<span class="speceff-common">Rash,</span>
<span class="speceff-life">Stevens-Johnson syndrome</span>. 
      <h1><a name="interactions">Interactions</a></h1><span class="typehead">Drug:</span> Administration with <b>amiodarone,</b>
<b>bepridil,</b>
<b>dihydroergotamine,</b>
<b>ergotamine,</b>
<b>lidocaine,</b>
<b>midazolam,</b>
<b>quinidine,</b>
<b>triazolam,</b> and <span class="classification">tricyclic antidepressants</span> may cause life-threatening reactions; <b>rifampin,</b>
<b>rifabutin,</b>
<span class="classification">oral contraceptives</span>, <b>phenobarbital,</b>
<b>phenytoin,</b>
<b>carbamazepine</b> decrease <b>amprenavir</b> concentrations; <b>amprenavir</b> may increase <b>dihydroergotamine,</b>
<b>ergotamine sildenafil</b> concentrations and toxicity; <b>amprenavir</b> may decrease <b>methadone</b> levels; monitor INR with <b>warfarin; oral solution</b> may cause antabuse reaction with <b>disulfiram, metronidazole.</b>
<span class="typehead">Food:</span> Decreased absorption with high-fat meal. <span class="typehead">Herbal:</span>
<b>St. John's wort</b> may decrease antiretroviral activity. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> Oral solution is less absorbed than capsules.  <span class="typehead">Peak:</span> 12 h. <span class="typehead"> Distribution:</span> 90% bound to plasma proteins. <span class="typehead">Metabolism:</span> Metabolized in liver by CYP3A4. <span class="typehead">Elimination:</span> 14% excreted in urine, 75% excreted in feces as metabolites. <span class="typehead"> Half-Life:</span> 7.110.6 h. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Monitor for therapeutic effectiveness which is indicated by elevated CD<sub>4</sub> count &amp; decreased HIV RNA copies.
         </li>
<li>Monitor for &amp; promptly notify physician of severe skin rash.</li>
<li>Lab tests: Monitor blood glucose &amp; HbA<sub>1c</sub>, Hgb &amp; Hct, and lipid profile at periodic intervals.
         </li>
<li>
            							Note: Monitor blood levels for coadministered drugs including amiodarone, lidocaine, phenobarbital, phenytoin, quinidine, tricyclic
            antidepressants; monitor PT and INR with warfarin.
            						
         </li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Follow directions for taking this drug (see <small>ADMINISTRATION</small>).
         </li>
<li>Take drug exactly as prescribed at the indicated times. Missed dose: if less than 4 h, wait until the next scheduled dose;
            otherwise, take immediately.
         </li>
<li>Do not take supplemental vitamin E with this drug unless approved by physician.</li>
<li>Notify physician promptly about skin rash, nausea, vomiting, diarrhea, numbness or tingling around mouth or hands &amp; feet.</li>
<li>Inform physician of all other prescription/nonprescription drugs being taken. Serious interactions can occur.</li>
<li>Use alternative barrier contraceptives rather than hormonal contraceptives while taking this drug.</li>
<li>
            							Note: Redistribution/accumulation of body fat may occur.
            						
         </li>
<li>
            							Note: Diabetics may experience loss of glycemic control.
            						
         </li>
<li>Do not breast feed while taking this drug.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>